A small tool to view real-world ActivityPub objects as JSON! Enter a URL
or username from Mastodon or a similar service below, and we'll send a
request with
the right
Accept
header
to the server to view the underlying object.
{
"@context": [
"https://www.w3.org/ns/activitystreams",
{
"ostatus": "http://ostatus.org#",
"atomUri": "ostatus:atomUri",
"inReplyToAtomUri": "ostatus:inReplyToAtomUri",
"conversation": "ostatus:conversation",
"sensitive": "as:sensitive",
"toot": "http://joinmastodon.org/ns#",
"votersCount": "toot:votersCount",
"Hashtag": "as:Hashtag"
}
],
"id": "https://mstdn.social/users/jackhutton/statuses/113209944560887580",
"type": "Note",
"summary": null,
"inReplyTo": null,
"published": "2024-09-27T14:17:43Z",
"url": "https://mstdn.social/@jackhutton/113209944560887580",
"attributedTo": "https://mstdn.social/users/jackhutton",
"to": [
"https://www.w3.org/ns/activitystreams#Public"
],
"cc": [
"https://mstdn.social/users/jackhutton/followers"
],
"sensitive": false,
"atomUri": "https://mstdn.social/users/jackhutton/statuses/113209944560887580",
"inReplyToAtomUri": null,
"conversation": "tag:mstdn.social,2024-09-27:objectId=442767312:objectType=Conversation",
"content": "<p>Gifted article [The Washington Post] FDA approves a novel drug for schizophrenia, a potential ‘game changer’</p><p>The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna Therapeutics. By Daniel Gilbert</p><p><a href=\"https://wapo.st/47JyDSn\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://</span><span class=\"\">wapo.st/47JyDSn</span><span class=\"invisible\"></span></a><br /><a href=\"https://mstdn.social/tags/schizophrenia\" class=\"mention hashtag\" rel=\"tag\">#<span>schizophrenia</span></a></p>",
"contentMap": {
"en": "<p>Gifted article [The Washington Post] FDA approves a novel drug for schizophrenia, a potential ‘game changer’</p><p>The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna Therapeutics. By Daniel Gilbert</p><p><a href=\"https://wapo.st/47JyDSn\" target=\"_blank\" rel=\"nofollow noopener noreferrer\" translate=\"no\"><span class=\"invisible\">https://</span><span class=\"\">wapo.st/47JyDSn</span><span class=\"invisible\"></span></a><br /><a href=\"https://mstdn.social/tags/schizophrenia\" class=\"mention hashtag\" rel=\"tag\">#<span>schizophrenia</span></a></p>"
},
"attachment": [],
"tag": [
{
"type": "Hashtag",
"href": "https://mstdn.social/tags/schizophrenia",
"name": "#schizophrenia"
}
],
"replies": {
"id": "https://mstdn.social/users/jackhutton/statuses/113209944560887580/replies",
"type": "Collection",
"first": {
"type": "CollectionPage",
"next": "https://mstdn.social/users/jackhutton/statuses/113209944560887580/replies?only_other_accounts=true&page=true",
"partOf": "https://mstdn.social/users/jackhutton/statuses/113209944560887580/replies",
"items": []
}
}
}